Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 5, 2015, Pages 712-718

  Goldthorpe, Heather ^a,b   Jiang, Jin Yi ^a,b   Taha, Mohamad ^a,b   Deng, Yupu ^a   Sinclair, Tammy ^a   Ge, Cindy X ^a   Jurasz, Paul ^c   Turksen, Kursad ^a,b   Mei, Shirley H J ^a   Stewart, Duncan J ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; Endothelial cell; Pulmonary arterial hypertension; Transgenic mice

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD68 ANTIGEN; FAS ANTIGEN; FK 506 BINDING PROTEIN; NERVE GROWTH FACTOR RECEPTOR; AP20187; FADD PROTEIN, MOUSE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS PROTEIN, MOUSE; HYBRID PROTEIN; TACROLIMUS; TEK PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE CONSTRUCT; HUMAN; HUMAN TISSUE; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VASCULAR OBSTRUCTIVE DISEASE; VASCULAR LESION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG; METABOLISM; PATHOLOGY; PLASMID; PROTEIN MULTIMERIZATION; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DISEASE MODELS, ANIMAL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION; HYPERTENSION, PULMONARY; LUNG; MICE; MICE, TRANSGENIC; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN MULTIMERIZATION; PULMONARY ARTERY; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSFECTION;

EID: 84956580896     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0311OC     Document Type: Article

References (24)

1. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension: A national prospective study. Ann Intern Med 1987;107:216-223.
2. Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: Apoptosis, proliferation, interaction and transdifferentiation. Respir Res 2009;10:95.
3. Fishman AP. Changing concepts of the pulmonary plexiform lesion. Physiol Res 2000;49:485-492.
4. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15:427-438.
5. Jurasz P, Courtman D, Babaie S, Stewart DJ. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials. Pharmacol Ther 2010;126:1-8.
6. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips III JA, Loyd JE, Nichols WC, Trembath RC; International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-b receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84.
7. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-b family. J Med Genet 2000;37:741-745.
8. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006;98:209-217.
9. Burnett SH, Kershen EJ, Zhang J, Zeng L, Straley SC, Kaplan AM, Cohen DA. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J Leukoc Biol 2004;75: 612-623.
10. 2+ signalling. Eur J Pharmacol 2013;700:181-193.
11. van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 2005;288:L167-L178.
12. Teng PI, Dichiara MR, Kömüves LG, Abe K, Quertermous T, Topper JN. Inducible and selective transgene expression in murine vascular endothelium. Physiol Genomics 2002;11:99-107.
13. Voelkel NF, Cool C. Pathology of pulmonary hypertension. Cardiol Clin 2004;22:343-351, .
14. Thomis DC, Marktel S, Bonini C, Traversari C, Gilman M, Bordignon C, Clackson T. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Blood 2001;97: 1249-1257.
15. Dorfmüller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.
16. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013;38: 792-804.
17. McCubbrey AL, Curtis JL. Efferocytosis and lung disease. Chest 2013;143:1750-1757.
18. Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, Langley RR, Fidler IJ, Pasqualini R, Tuder RM, Arap W. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem 2008;283:29447-29460.
19. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012;122:2749-2755.
20. Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc 2006;3:687-690.
21. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997;81:567-574.
22. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
23. Gomez-Arroyo J, Saleem SJ, Mizuno S, Syed AA, Bogaard HJ, Abbate A, Taraseviciene-Stewart L, Sung Y, Kraskauskas D, Farkas D, et al. A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol 2012;302:L977-L991.
24. Abe K, Toba M, Alzoubi A, Ito M, Fagan KA, Cool CD, Voelkel NF, McMurtry IF, Oka M. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation 2010;121: 2747-2754.